AngioDynamics Inc. | Income Statement

Fiscal year is June-May. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
350,596.00
352,832.00
351,474.00
351,480.00
344,285.00
Cost of Goods Sold (COGS) incl. D&A
191,379.00
193,197.00
197,538.00
190,770.00
184,045.00
Gross Income
159,217.00
159,635.00
153,936.00
160,710.00
160,240.00
SG&A Expense
137,325.00
137,425.00
139,379.00
135,494.00
133,392.00
EBIT
21,892.00
22,210.00
-
25,216.00
26,240.00
Unusual Expense
8,952.00
23,204.00
13,539.00
12,249.00
15,682.00
Non Operating Income/Expense
3,544.00
3,812.00
886.00
281.00
31.00
Interest Expense
3,656.00
3,197.00
3,385.00
2,839.00
3,062.00
Pretax Income
5,740.00
7,999.00
3,253.00
9,847.00
7,465.00
Income Tax
3,074.00
4,731.00
40,337.00
4,839.00
8,870.00
Consolidated Net Income
2,666.00
3,268.00
43,590.00
5,008.00
16,335.00
Net Income
2,666.00
3,268.00
43,590.00
5,008.00
16,335.00
Net Income After Extraordinaries
2,666.00
3,268.00
43,590.00
5,008.00
16,335.00
Net Income Available to Common
2,666.00
3,268.00
43,590.00
5,008.00
16,335.00
EPS (Basic)
0.08
0.09
1.21
0.14
0.44
Basic Shares Outstanding
35,136.00
35,683.00
36,161.40
36,616.90
37,074.80
EPS (Diluted)
0.08
0.09
1.21
0.14
0.44
Diluted Shares Outstanding
35,440.00
35,683.00
36,161.40
36,959.30
37,539.40
EBITDA
50,049.00
52,702.00
40,721.00
48,512.00
49,403.00
Other Operating Expense
-
-
-
-
608.00
Non-Operating Interest Income
-
4.00
-
-
-

About AngioDynamics

View Profile
Address
14 Plaza Drive
Latham New York 12110
United States
Employees -
Website http://www.angiodynamics.com
Updated 07/08/2019
AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products.